Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision approach.
249 employees · est. 2021 · South San Francisco, United...
RetinAI
Improving R&D of first-in-human drug candidates in pharma. Supercharging clinical trials. Elevating the quality of care.
43 employees · est. 2017 · Bern, Switzerland
RetinAI is the older company (2021 vs 2017); Alumis is the larger of the two.
Side-by-Side Comparison
| Metric | Alumis | RetinAI |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2017 older |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Bern, Switzerland |
| Employees | ||
| Employees | 249 larger | 43 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | AI, Computing, Health Care |
| Funding Stage | ||
| Funding Stage | Series C | Series B |
| Total Funding | ||
| Total Funding | $529.00M | $15.14M |
| Funding Rounds | ||
| Funding Rounds | 3 | 8 |
| Services | ||
| Services | Development of targeted therapies, Clinical trial management, Proprietary data analytics for precision medicine, Patient resources and expanded access policy | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with immune-mediated diseases, Healthcare providers, Medical researchers, Investors in biotech and pharmaceutical sectors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immune-mediated Diseases, Precision Medicine, Targeted Therapies, Drug Development, Autoimmune Diseases, Immunology, Pharmaceuticals, Integrated Therapy Development, Immunosuppression Alternatives, Patient-centric Solutions, Disease-specific Drug Targeting, Therapeutic Innovation, Healthcare Analytics | Medical Image Analysis, Med-tech, Ophthalmology, Optical Coherence Tomography, Fundus Image Photography, Retinal Angiography, Age-related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Multiple Sclerosis, Alzheimer, Parkinson, Digital Health |
| Website | ||
| Website | alumis.com | retinai.com |
About Alumis
Alumis, founded in 2021 and headquartered in the United States, is making strides in the biotechnology, health care, and life sciences industries. The company is committed to transforming the lives of patients with immune-mediated diseases through a precise, targeted approach. By focusing on optimiz...
About RetinAI
RetinAI is a Swiss & US-based software company focused on improving and supporting R&D of first-in-human drug candidates, supercharging management and oversight of clinical trials, and enabling the research needed to elevate the quality of care on patients with eye diseases. The company's slogan "Im...
We will tell you when either one moves
BounceWatch watches Alumis and RetinAI for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Alumis and RetinAI — by email.
Frequently Asked Questions
Compare Alumis with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Alumis on 9 Jun 2026, and RetinAI on 24 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.